Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Annalisa Jenkins Insider Profile
4 Followers
Annalisa Jenkins, Director at Ardelyx, holds 33.47K shares in Ardelyx (Ticker: ARDX), holds ― shares in Dimension Therapeutics Inc (Ticker: DMTX), holds ― shares in OncoSec Medical (Ticker: ONCS).
Annalisa Jenkins has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Annalisa Jenkins holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Annalisa Jenkins
Annalisa Jenkins's Trading History
Ardelyx
Jun 17, 2019
Director
Uninformative Buy
―
$211.20K
Dimension Therapeutics Inc
―
―
―
―
OncoSec Medical
―
Director
―
―
AgeX Therapeutics
―
Director
―
―
Avrobio
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Annalisa Jenkins's performance on stock
You May Also Like
Annalisa Jenkins insider profile FAQ
What is the percentage of profitable transactions made by Annalisa Jenkins?
The percentage of profitable transactions made by Annalisa Jenkins is ―.
What is the average return per transaction made by Annalisa Jenkins?
The average return per transaction made by Annalisa Jenkins is ―.
What stocks does Annalisa Jenkins hold?
Annalisa Jenkins holds: ARDX, DMTX, ONCS, AGE, AVRO stocks.
What was Annalisa Jenkins’s latest transaction?
Annalisa Jenkins latest transaction was an Uninformative Buy of ―.
What was Annalisa Jenkins's most profitable transaction?
Annalisa Jenkins’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Annalisa Jenkins's role in Ardelyx?
Annalisa Jenkins's role in Ardelyx is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.